NLRP3 and neurodegenerative disease: Overall, these results highlight the potential of certain Ramalin derivatives in modulating neuroinflammatory responses through NLRP3 inhibition, which could be advantageous for developing therapeutics targeting neurodegenerative diseases like AD.